Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1998 1
1999 1
2001 1
2009 1
2010 1
2012 1
2015 3
2016 3
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Chang YY. Chen SW, et al. Anticancer Res. 2019 Jun;39(6):3015-3024. doi: 10.21873/anticanres.13434. Anticancer Res. 2019. PMID: 31177143
AIM: To compare the advantage of image-guided brachytherapy (IGBT) over conventional two-dimensional brachytherapy (2DBT) in patients with advanced cervical squamous cell carcinoma. PATIENTS AND METHODS: This study included 253 patients with sta …
AIM: To compare the advantage of image-guided brachytherapy (IGBT) over conventional two-dimensional brachytherapy (2DBT) in patients with …
Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
Okonogi N, Wakatsuki M, Kato S, Shiba S, Kobayashi D, Kiyohara H, Karasawa K, Ohno T, Nakano T, Kamada T, Shozu M; WORKING GROUP OF GYNECOLOGICAL TUMORS. Okonogi N, et al. Anticancer Res. 2018 Jan;38(1):457-463. doi: 10.21873/anticanres.12244. Anticancer Res. 2018. PMID: 29277809 Clinical Trial.
BACKGROUND/AIM: To evaluate the long-term outcomes of carbon-ion radiotherapy (C-ion RT) for locally advanced cervical squamous cell carcinoma (LAC-SqCC) in 2 prospective phase I/II studies. ...
BACKGROUND/AIM: To evaluate the long-term outcomes of carbon-ion radiotherapy (C-ion RT) for locally advanced cervical squa
Expression of ERCC1 and TUBB3 in locally advanced cervical squamous cell cancer and its correlation with different therapeutic regimens.
Zwenger AO, Grosman G, Iturbe J, Leone J, Vallejo CT, Leone JP, Verdera PP, Pérez JE, Leone BA. Zwenger AO, et al. Int J Biol Markers. 2015 Jul 22;30(3):e301-14. doi: 10.5301/jbm.5000161. Int J Biol Markers. 2015. PMID: 26165688 Free article.
We assessed the role of ERCC1 and TUBB3 expressions as predictive and prognostic factors in locally advanced cervical squamous cell carcinoma (LACSCC) patients treated with different neoadjuvant regimens. ...Both groups were compared with standa …
We assessed the role of ERCC1 and TUBB3 expressions as predictive and prognostic factors in locally advanced cervical squam
Role of difucosylated Lewis Y antigen in outcome of locally advanced cervical squamous cell carcinoma treated with cisplatin regimen.
Leone J, Perez JE, Dominguez ME, Iturbe J, Leone JP, Mac Donnell MC, Grosman G, Vallejo CT, Leone BA, Zwenger AO. Leone J, et al. Int J Biol Markers. 2016 Jul 30;31(3):e300-8. doi: 10.5301/jbm.5000206. Int J Biol Markers. 2016. PMID: 27197582 Free article.
BACKGROUND: Several mechanisms are involved in the development of resistance to therapy in locally advanced cervical squamous cell carcinoma (LACSCC). Studies have shown that CD44 and Lewis Y antigen (LeY) form a complex that is associated with …
BACKGROUND: Several mechanisms are involved in the development of resistance to therapy in locally advanced cervical squamo
HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma.
Huang X, Liu M, Sun H, Wang F, Xie X, Chen X, Su J, He Y, Dai Y, Wu H, Shen L. Huang X, et al. Int J Clin Exp Pathol. 2015 Apr 1;8(4):4054-63. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097593 Free PMC article.
The mechanism by which overexpression of hexokinase 2 (HK2) indicates locally advanced cervical squamous cell carcinoma (LACSCC) with radio-resistance is still unknown despite being an independent biomarker of poor prognosis. ...
The mechanism by which overexpression of hexokinase 2 (HK2) indicates locally advanced cervical squamous cell
Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy.
Wang J, Chai YL, Wang T, Liu JH, Dai PG, Liu Z. Wang J, et al. Exp Mol Pathol. 2015 Jun;98(3):407-10. doi: 10.1016/j.yexmp.2015.03.014. Epub 2015 Mar 13. Exp Mol Pathol. 2015. PMID: 25773678
OBJECTIVE: The objective of this study was to investigate the predictive value of common genetic alterations of PI3K/AKT/mTOR and Ras/Raf/MAPK pathways in patients with locally advanced cervical squamous cell carcinoma (LACSCC) treated with cisp …
OBJECTIVE: The objective of this study was to investigate the predictive value of common genetic alterations of PI3K/AKT/mTOR and Ras/Raf/MA …
The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X, Wei LC, Zhang Y, Zhao LN, Li WW, Ping LJ, Dang YZ, Hu J, Shi M. Li X, et al. Int J Gynecol Cancer. 2016 Oct;26(8):1472-9. doi: 10.1097/IGC.0000000000000778. Int J Gynecol Cancer. 2016. PMID: 27400321
BACKGROUND: The purpose of this study is to determine the prognostic significance of pelvic lymph node (PLN) characteristics and perform risk stratification in patients undergoing concurrent chemoradiotherapy for locally advanced cervical squamous cell
BACKGROUND: The purpose of this study is to determine the prognostic significance of pelvic lymph node (PLN) characteristics and perform ris …
Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
Aoki Y, Tomita M, Sato T, Watanabe M, Kase H, Fujita K, Kurata H, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2001 Nov;83(2):263-7. doi: 10.1006/gyno.2001.6371. Gynecol Oncol. 2001. PMID: 11606081 Clinical Trial.
OBJECTIVE: To evaluate the response rate and toxicity and to improve survival, neoadjuvant chemotherapy (NAC) was utilized in patients younger than 50 years with locally advanced cervical squamous cell carcinoma. METHODS: Twenty-one patients wer …
OBJECTIVE: To evaluate the response rate and toxicity and to improve survival, neoadjuvant chemotherapy (NAC) was utilized in patients young …
Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.
Wang YY, Bai ZL, He JL, Yang Y, Zhao R, Hai P, Zhe H. Wang YY, et al. Dis Markers. 2016;2016:3740794. doi: 10.1155/2016/3740794. Epub 2016 Mar 20. Dis Markers. 2016. PMID: 27087737 Free PMC article.
The aim of this study was to explore the relationship between neutrophil-related factors, including neutrophil-lymphocyte ratio (NLR) and the responses of neutrophil to granulocyte colony-stimulating factors (RNG), and the prognosis of patients with locally advanced cer
The aim of this study was to explore the relationship between neutrophil-related factors, including neutrophil-lymphocyte ratio (NLR) and th …
16 results